LABORIE has completed its acquisition of Medical Measurement Systems (“MMS”). MMS is headquartered in Enschede, The Netherlands with a German subsidiary in Bottrop and US operations in Dover, New Hampshire. MMS is a global market leader in Gastrointestinal Diagnostics and Urodynamics.
LABORIE’s acquisition of MMS extends its Gastroenterology product offering following its acquisition of Unisensor in October 2014. Additionally, MMS’ Urodynamic product lines complement LABORIE’s Urodynamic product offering and extend its global reach.
“This is a very strategic acquisition for LABORIE,” stated Brian Ellacott, LABORIE President and CEO. “MMS has developed user-friendly products based on a unique platform that simultaneously supports Urology and Gastroenterology customers. We see tremendous opportunities to leverage this single platform across all our products and extend our global reach through the MMS global distribution network. We see this as a very complementary acquisition.”
MMS President, Arjen de Weerd stated, “We are very pleased to be part of the LABORIE team. The combined resources of these two innovative companies, will allow us to develop the “next generation” products our customers are requesting and expand our footprint globally. Both I and co-founder Jan-Willem van der Wal are eager to participate with the LABORIE team in building truly innovative products for the GI and Urology markets.”
LABORIE (www.laborie.com), headquartered in Toronto, Canada, is a leading global developer, manufacturer and marketer of innovative medical technology and consumables for the diagnosis and treatment of Urinary and Fecal Incontinence, as well as other pelvic floor disorders in the Urology, Gynecology, and Colorectal fields.
Laborie Medical Technologies Inc. (LABORIE), a leading diagnostic and therapeutic medical technology company, today announced the first Optilume® procedures were performed in Mannheim, Germany on January 22, 2021 by Dr. Georgi Tosev (Mannheim Urology).
Transaction demonstrates LABORIE’s commitment to providing innovative solutions to urologists globally LABORIE to invest $15 million in Urotronic Series C financing LABORIE secures option to acquire Urotronic’s Optilume™ technology
Laborie Medical Technologies (LABORIE), a leading diagnostic and therapeutic medical technology company, in partnership with Signet Healthcare Partners, a growth equity firm specializing in healthcare investments, announced the close of the acquisition of GI Supply, a leader in specialty endoscopy and paracentesis products for gastroenterologists, colorectal surgeons, and interventional radiologists.